A leading cancer specialist tells the compelling stories of three adult leukemia patients and their treatments, the disease itself, and the drugs developed to t...
How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin.Foo...
The fifth edition of the only comprehensive text dealing exclusively with rare or infrequently encountered malignancies in adults and children is an essential r...
The only text dealing exclusively with rare or infrequently encountered malignancies in adults and childrenNow in its Fourth Edition, Textbook of Uncommon Cance...